#AANAM – Onpattro Continues Improving Quality of Life in Ongoing Study

#AANAM – Onpattro Continues Improving Quality of Life in Ongoing Study

292813

#AANAM – Onpattro Continues Improving Quality of Life in Ongoing Study

Editor’s note: The FAP News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. Onpattro (patisiran) over two years continues to ease symptoms of polyneuropathy and to improve quality of life among people with familial amyloid polyneuropathy (FAP), according to data from an ongoing global extension study. Findings from the study were presented by Michael Polydefkis, MD, a professor at Johns…

You must be logged in to read/download the full post.